Pregabalin + Duloxetine in pharma franchise in Mizoram

Pregabalin + Duloxetine in PCD pharma franchise in Shimla

Pregabalin + Duloxetine in top pharma company in Bharuch

Pregabalin + Duloxetine in pcd pharma supplier in Udupi

Pregabalin + Duloxetine in phama franchise company in India
Pregabalin + Duloxetine in phama distributor in Bhubaneswar

Home/Products /pregabalin-75mg-duloxetine-30mg-caps-delayed-release-capsule

About the Product

Description


Pregahike D 75/30 Capsule combines two powerful medications, Pregabalin (75mg) and Duloxetine (30mg), in a single capsule to effectively manage a variety of conditions. Pregabalin is primarily used to treat neuropathic pain, generalized anxiety disorder, and seizures, while Duloxetine is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) that is commonly used to treat depression, anxiety, and chronic pain.

This delayed-release formulation ensures that the active ingredients are released gradually, improving the duration of therapeutic effects and minimizing potential side effects. Pregahike D 75/30 Capsule provides a comprehensive treatment option for individuals suffering from chronic pain conditions, anxiety disorders, and other related conditions.

Pregabalin works by calming overactive nerves, which helps alleviate the symptoms of neuropathic pain, seizures, and anxiety. It is often used in the treatment of conditions like diabetic neuropathy, fibromyalgia, and post-herpetic neuralgia. Duloxetine plays a crucial role in managing mood disorders such as depression and anxiety by balancing serotonin and norepinephrine levels in the brain. Together, these ingredients provide effective relief from both physical and psychological symptoms, improving the quality of life for those with chronic pain and anxiety disorders.

Pregahike D 75/30 Capsule is suitable for individuals diagnosed with conditions such as generalized anxiety disorder, diabetic neuropathy, fibromyalgia, and chronic musculoskeletal pain. It is important to follow the prescribed dosage to achieve the best results and avoid potential side effects.

Common side effects may include dizziness, drowsiness, nausea, dry mouth, or constipation. Consult your healthcare provider if any severe reactions occur.

Pregahike D 75/30 Capsule is indicated for the treatment of neuropathic pain, generalized anxiety disorder, and fibromyalgia.

Pregahike D 75/30 Capsule should be used under medical supervision, especially in patients with a history of seizures, liver or kidney problems.

Store in a cool, dry place, away from direct sunlight. Keep the container tightly closed to maintain product quality.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pregahike D 75/30 Capsule in the PCD pharma franchise market?

Pregahike D 75/30 Capsule, containing Pregabalin 75mg and Duloxetine 30mg (Delayed Release), has strong demand in the neurology and neuropathic pain management segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their neuro and chronic care portfolio.

Why should medical distributors include Pregahike D 75/30 Capsule in their product range?

Medical distributors and agencies can benefit from the increasing market demand for medicines used in neuropathic pain, diabetic neuropathy, fibromyalgia, nerve damage, and chronic pain management. Pregahike D 75/30 Capsule helps strengthen a comprehensive neuro care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Pregahike D 75/30 Capsule?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pregahike D 75/30 Capsule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Pregahike D 75/30 Capsule distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted neurology and pain management product range when partnering for Pregahike D 75/30 Capsule distribution.

How can I become a distributor or franchise partner for Pregahike D 75/30 Capsule?

Medical distributors, stockists, and wholesalers interested in Pregahike D 75/30 Capsule can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.